Progress of transcranial magnetic stimulation on cognitive function in Alzheimer's disease

QIN Xiao-hong, JIANG Fu-gui, LIU Xue-mei, XIAO Jun

Chinese Journal of Alzheimer's Disease and Related Disorders ›› 2021, Vol. 4 ›› Issue (4) : 328-332.

PDF(877 KB)
Home Journals Chinese Journal of Alzheimer's Disease and Related Disorders
Chinese Journal of Alzheimer's Disease and Related Disorders

Abbreviation (ISO4): Chinese Journal of Alzheimer's Disease and Related Disorders      Editor in chief: Jun WANG

About  /  Aim & scope  /  Editorial board  /  Indexed  /  Contact  / 
PDF(877 KB)
Chinese Journal of Alzheimer's Disease and Related Disorders ›› 2021, Vol. 4 ›› Issue (4) : 328-332. DOI: 10.3969/j.issn.2096-5516.2021.04.015
Review

Progress of transcranial magnetic stimulation on cognitive function in Alzheimer's disease

Author information +
History +

Abstract

Alzheimer's disease (AD), a chronic progressive degenerative disease of the central nervous system, is the most common type of cognitive impairment in the elderly. As a safe and non-invasive brain stimulation technique, repetitive transcranial magnetic stimulation (TMS) has been proved to be effective in improving cognitive function of AD by a large number of studies.This paper reviews the mechanism and clinical studies of rTMS in the treatment of cognitive function of AD in the past decade.The rTMS on cognitive function in patients with AD is unclear, the mechanism of curative effect research mainly focus on regulating synaptic plasticity, regulate gene and protein expression, inhibition of cell apoptosis and regulate blood flow redistribution, etc., clinical research groups have focused on patients with mild-to-moderate and AD and MCI, through neuropsychological assessment scale to assess their language, memory and other cognitive changes.This paper made a review and found that high-frequency rTMS can improve the cognitive areas of AD, such as language, memory and learning ability. However, it is still necessary to expand the sample size, study population type and scope, and extend the follow-up time to further verify the effect of rTMS on the cognitive function of AD patients.

Key words

Alzheimer's disease / repetitive transcranial magnetic stimulation / cognitive function

Cite this article

Download Citations
QIN Xiao-hong , JIANG Fu-gui , LIU Xue-mei , et al. Progress of transcranial magnetic stimulation on cognitive function in Alzheimer's disease[J]. Chinese Journal of Alzheimer's Disease and Related Disorders. 2021, 4(4): 328-332 https://doi.org/10.3969/j.issn.2096-5516.2021.04.015

References

[1]
Wang X, Mao Z, Ling Z, et al. Repetitive transcranial magnetic stimulation for cognitive impairment in Alzheimer's disease: a meta-analysis of randomized controlled trials[J]. Neurol, 2020, 267(3):791-801.
[2]
Celsis P. Age-related cognitive decline, mild cognitive impairment or preclinical Alzheimer's disease?[J]. Annals of Medicine, 2000, 32(1): 6-14.
With the promising development of effective treatment, significant improvement in the very early diagnosis of Alzheimer's disease (AD) is required. There is vast agreement that a decline in memory, especially in verbal episodic memory, is the earliest and perhaps the most sensitive sign of incipient AD at the preclinical stage. However, this review offers evidence that impairment in episodic memory can be observed in normal elderly people as well as in aged subjects with mild cognitive impairment (MCI), a large proportion of whom will, however, not convert to dementia. Quantitative measurement of atrophy and brain activation in the hippocampal-parahippocampal formation by using structural and functional magnetic resonance imaging may help to distinguish the MCI decliners from the nondecliners. Cerebrospinal fluid levels of tau protein and Abet1-42 peptide, together with the presence of an apolipoprotein (apo)E epsilon4 allele may also increase our confidence in the early positive diagnosis of AD. This review concludes, however, that while adequate for constituting groups of patients in a research perspective, the extensive diagnostic procedure based on specific cognitive testing, neuroimaging and biological investigations is still out of reach for the practitioner.
[3]
Wilson RS, Segawa E, Boyle PA, et al. The natural history of cognitive decline in Alzheimer's disease[J]. Psychology & Aging, 2012, 27(4): 1008-1017.
[4]
Scheltens P, Blennow K, Breteler MM, et al. Alzheimer's disease[J]. Postgraduate Medical Journal, 2016, 388(10043): 505-517.
[5]
Luber B, Lisanby SH. Enhancement of human cognitive performance using transcranial magnetic stimulation (TMS)[J]. Neuroimage, 2014, 3(3): 961-970.
[6]
Mok RM, Myers NE, Wallis G, et al. Behavioral and Neural Markers of Flexible Attention over Working Memory in Aging[J]. Cereb Cortex. 2016, 26(4): 1831-1842.
[7]
Liao X, Li G, Wang A, et al. Repetitive Transcranial Magnetic Stimulation as an Alternative Therapy for Cognitive Impairment in Alzheimer's Disease: A Meta-Analysis[J]. Journal of Alzheimer's Disease, 2015, 48(2): 463-472.
[8]
Ni Z, Chen R. Transcranial magnetic stimulation to understand pathophysiology and as potential treatment for neurodegenerative diseases[J]. Transl Neurodegener, 2015,(1):184-195.
[9]
Andreou AP, Holland PR, Akerman S, et al. Transcranial magnetic stimulation and potential cortical and trigeminothalamic mechanisms in migraine[J]. Brain, 2016, 139(7): 2002-2014.
[10]
Vacas SM, Stella F, Loureiro JC, et al. Noninvasive brain stiAge-related cognitive decline, mild cognitive impairment or preclinical Alzheimer's disease?mulation for behavioural and psychological symptoms of dementia: A systematic review and meta-analysis[J]. Int J Geriatr Psychiatry, 2019, 34(9): 1336-1345
[11]
Zhao J, Li Z, Cong Y, et al. Repetitive transcranial magnetic stimulation improves cognitive function of Alzheimer's disease patients[J]. Oncotarget, 2017, 8(20): 33864-33871.
[12]
Rutherford G, Lithgow B, Moussavi Z, et al. Short and Long-term Effects of rTMS Treatment on Alzheimer's Disease at Different Stages: A Pilot Study[J]. Exp Neurosci, 2015, 9: 43-51.
[13]
Ahmed MA, Darwish ES, Khedr EM, et al. Effects of low versus high frequencies of repetitive transcranial magnetic stimulation on cognitive function and cortical excitability in Alzheimer's dementia[J]. Journal of Neurology, 2012, 259(1): 83-92.
[14]
Cotelli M, Calabria M, Manenti R, et al. Improved language performance in Alzheimer's disease following brain stimulation[J]. Neurol Neurosurg Psychiatry, 2011, 82(7): 794-797.
[15]
Wu Y, Xu W, Liu X, et al. Adjunctive treatment with high frequency repetitive transcranial magnetic stimulation for the behavioral and psychological symptoms of patients with Alzheimer's disease: a randomized, double-blind, sham-controlled study[J]. Shanghai Archives of Psychiatry, 2015, 27(5): 280-288.
[16]
Lefaucheur JP, Aleman A, Baeken C, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014-2018) [published correction appears in Clin Neurophysiol. 2020 May; 131(5): 1168-1169][J]. Clin Neurophysiol, 2020, 131(2): 474-528.
[17]
Brehmer Y, Kalpouzos G, Wenger E, et al. Plasticity of brain and cognition in older adults[J]. Psychol Res, 2014, 78(6): 790-802.
Aging is typically related to changes in brain and cognition, but the aging process is heterogeneous and differs between individuals. Recent research has started investigating the influence of cognitive and physical training on cognitive performance, functional brain activity, and brain structure in old age. The functional relevance of neural changes and the interactions among these changes following interventions is still a matter of debate. Here we selectively review research on structural and functional brain correlates of training-induced performance changes in healthy older adults and present exemplary longitudinal intervention studies sorted by the type of training applied (i.e., strategy-based training, process-specific training, and physical exercise). Although many training studies have been conducted recently, within each task domain, the number of studies that used comparable methods and techniques to assess behavioral and neural changes is limited. We suggest that future studies should include a multimodal approach to enhance the understanding of the relation between different levels of brain changes in aging and those changes that result from training. Investigating inter-individual differences in intervention-induced behavioral and neuronal changes would provide more information about who would benefit from a specific intervention and why. In addition, a more systematic examination of the time course of training-related structural and functional changes would improve the current level of knowledge about how learning is implemented in the brain and facilitate our understanding of contradictory results.
[18]
Shen C, Sun FL, Zhang RY, et al. Tetrahydroxystilbene glucoside ameliorates memory and movement functions, protects synapses and inhibits α-synuclein aggregation in hippocampus and striatum in aged mice[J]. Restor Neurol Neurosci, 2015, 33(4): 531-541.
[19]
Nam SM, Choi JH, Yoo DY, et al. Effects of curcumin (Curcuma longa) on learning and spatial memory as well as cell proliferation and neuroblast differentiation in adult and aged mice by upregulating brain-derived neurotrophic factor and CREB signaling[J]. Med Food, 2014, 17(6): 641-649.
[20]
Hernandez PJ, Abel T. The role of protein synthesis in memory consolidation: progress amid decades of debate[J]. Neurobiology of Learning & Memory, 2008, 89(3): 293-311.
[21]
Ma Q, Geng Y, Wang HL, et al. High Frequency Repetitive Transcranial Magnetic Stimulation Alleviates Cognitive Impairment and Modulates Hippocampal Synaptic Structural Plasticity in Aged Mice[J]. Front Aging Neurosci, 2019, 11: 235.
[22]
Chen X, Dong GY, Wang LX, et al. High-frequency transcranial magnetic stimulation protects APP/PS1 mice against Alzheimer's disease progress by reducing APOE and enhancing autophagy[J]. Brain Behav, 2020, 10(8): e01740.
[23]
Duff K, Planel E. Untangling memory deficits[J]. Nature Medicine, 2005, 11(8): 826.
[24]
Santacruz K, Lewis J, Spires T, et al. Tau suppression in a neurodegenerative mouse model improves memory function[J]. Science, 2005, 309(5733): 476-481.
Neurofibrillary tangles (NFTs) are the most common intraneuronal inclusion in the brains of patients with neurodegenerative diseases and have been implicated in mediating neuronal death and cognitive deficits. Here, we found that mice expressing a repressible human tau variant developed progressive age-related NFTs, neuronal loss, and behavioral impairments. After the suppression of transgenic tau, memory function recovered, and neuron numbers stabilized, but to our surprise, NFTs continued to accumulate. Thus, NFTs are not sufficient to cause cognitive decline or neuronal death in this model of tauopathy.
[25]
Li HL, Wang HH, Liu SJ, et al. Phosphorylation of tau antagonizes apoptosis by stabilizing beta-catenin, a mechanism involved in Alzheimer's neurodegeneration[J]. Proc Natl Acad Sci U S A, 2007, 104(9): 3591-3596.
[26]
Chen X, Chen S, Liang W, et al. Administration of Repetitive Transcranial Magnetic Stimulation Attenuates Aβ1-42 -Induced Alzheimer's Disease in Mice by Activating β-Catenin Signaling[J]. Biomed Research International, 2019, 2019: 1-8.
[27]
Shang YQ, Xie J, Peng W, et al. Network-wise cerebral blood flow redistribution after 20Hz rTMS on left dorso-lateral pre-frontal cortex[J]. European Journal of Radiology, 2018, 101: 144-148.
[28]
Koch G, Bonnì S, Pellicciari MC, et al. Transcranial magnetic stimulation of the precuneus enhances memory and neural activity in prodromal Alzheimer's disease[J]. Neuroima ge, 2017,302-311.
[29]
Alcala-Lozano R, Morelos-Santana E, Cortes-Sotres JF, et al. Similar clinical improvement and maintenance after rTMS at 5Hz using a simple vs. complex protocol in Alzheimer's disease[J]. Brain Stimul, 2018, 11: 625-627.
[30]
Lee J, Choi BE, Oh E, et al. Treatment of Alzheimer's disease with repetitive transcranial magnetic stimulation combined with cognitive training: a prospective, randomized, double blind, placebo-controlled study[J]. Clin Neurol, 2016, 12: 57-64.
[31]
Rabey JM, Dobronevsky E, Aichenbaum S, et al. Repetitive transcranial magnetic stimulation combined with cognitive training is a safe and effective modality for the treatment of Alzheimer's disease: a randomized, double-blind study[J]. Neural Transm (Vienna), 2013, 120: 813-819.
[32]
Sabbagh M, Sadowsky C, Tousi B, et al. Effects of a combined transcranial magnetic stimulation (TMS) and cognitive training intervention in patients with Alzheimer's disease[J]. Alzheimer's Dement, 2020, 16(4): 641-650.
[33]
Eliasova I, Anderkova L, Marecek R, et al. Non-invasive brain stimulation of the right inferior frontal gyrus may improve attention in early Alzheimer's disease: A pilot study[J]. Journal of the Neurological ences, 2014, 346(1-2): 318-322.
[34]
Rabey JM, Dobronevsky E. Repetitive transcranial magnetic stimulation (rTMS) combined with cognitive training is a safe and effective modality for the treatment of Alzheimer's disease: clinical experience[J]. Journal of Neural Transmission, 2016, 123(12): 1-7.
[35]
柴宁, 王岚, 王学义, 等. 重复经颅磁刺激治疗阿尔茨海默病的研究进展[J]. 中华精神科杂志, 2013, 46(2):126-128.
PDF(877 KB)

Accesses

Citation

Detail

Sections
Recommended

/